Alaunos Therapeutics | Capital Ordinaire



Ordinary Share Capital Changement Date
Adcock Ingram Holdings ZAR 14.68M 427K 2024-06
Alaunos Therapeutics USD 2K 0 2024-12
Amgen USD 33.53B 140M 2024-12
AstraZeneca USD 388M 0 2024-12
Baxter International USD 683M 0 2024-12
Biogen USD 100K 0 2024-12
Bioline Rx USD 34.43M 19K 2024-09
Bristol-Myers Squibb USD 292M 0 2024-12
Celltrion KRW 220.45B 27.97M 2024-09
Corcept Therapeutics USD 136K 1000 2024-12
Cspc Pharmaceutical CNY 11.03B 26.91M 2024-12
Dianthus Therapeutics USD 31K 2K 2024-12
Ecofibre AUD 120.81M 134K 2024-06
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 0 2024-12
Incyte USD 193K 1000 2024-12
Ionis Pharmaceuticals USD 158K 0 2024-12
J&J USD 3.12B 0 2024-12
Kangmei Pharma CNY 13.86B 0 2024-09
Knight Therapeutics CAD 539.32M 1.63M 2024-09
Laboratorios Farma EUR 3.24M 0 2023-06
Malin Corporation EUR 200K 0 2024-06
Medical Developments International AUD 105.73M 0 2024-06
Merck USD 1.79B 0 2024-12
Neuren Pharmaceuticals AUD 165.27M 10.43M 2024-12
Novartis USD 793M 0 2024-12
Organigram Holdings CAD 892.59M 39.7M 2024-12
Pfizer USD 480M 0 2024-12
Pharma Mar EUR 10.93M 80K 2024-12
PTC Therapeutics USD 77K 1000 2024-12
Qiagen NV USD 2.6M 0 2024-09
Regeneron Pharmaceuticals USD 102K 0 2024-12
Roche Holding CHF 107M 0 2024-06
Sartorius EUR 69M 0 2025-03
Sino Biopharmaceutical CNY 414.38M 0 2024-12
TG Therapeutics USD 156K 0 2024-12
Tilray USD 93K 5K 2024-11
Zz Pientze Pharmaceu 603.32M 0 2024-09



Alaunos Therapeutics Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.